Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emergency Total Extracorporeal Life Support Versus Standard Advanced Cardiac Life Support With ECMO Bailout for Survival With Favorable Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest

NCT06692075 is registered in ClinicalTrials.gov with Taipei Medical University Shuang Ho Hospital as lead sponsor.

NCT NCT06692075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emergency Total Extracorporeal Life Support Versus Standard Advanced Cardiac Life Support With ECMO Bailout for Survival With Favorable Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest
Lead sponsor
Taipei Medical University Shuang Ho Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 1, 2024
Completion date
November 30, 2027
Enrollment
332 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

out-of-hospital cardiac arrest (ohca)